TOP STORY

Tamoxifen for breast cancer prevention does not benefit most women, UC Davis research shows

Most women at high risk for breast cancer do not increase their life expectancy by taking the drug tamoxifen, according to a new analysis by researchers from UC Davis, UC San Francisco, the University of Pittsburgh and McMaster University in Ontario, Canada. In addition, the researchers showed that tamoxifen is an extraordinarily expensive cancer-prevention strategy, costing as much as $1.3 million per year of life saved. (more...)

COMPLIANCE CORNER

Update on who’s who in compliance

HEADLINES

Regents vote to reinstate employee contributions to UC Retirement Plan

First group of employees completes leadership academy

Changes coming to School of Medicine faculty payroll statements

New retiree center seeks wider health system participation (photo)

UPCOMING EVENTS

Calendar

EMPLOYMENT OPPORTUNITIES

Job listings at UC Davis Health System